UPS Acquires Andlauer Healthcare Group for USD 1.6 Billion to Accelerate Healthcare Logistics Growth

UPS reaffirmed its commitment to growing its healthcare logistics business internationally by announcing the acquisition of Andlauer Healthcare Group (AHG) for about USD 1. 6 billion. Through the acquisition UPS Healthcare will be able to better serve its clients in the pharmaceutical, biotechnology and medical device industries by strengthening its capabilities in cold-chain logistics, specialized transportation, and healthcare warehousing solutions. The deal is anticipated to improve UPSs end-to-end healthcare supply chain services in both domestic and foreign markets. UPSs long-term goal of becoming a top supplier of sophisticated healthcare logistics services is in line with the agreement. Additionally, it increases the company's capacity to handle the increasing amount of expensive and temperature-sensitive medical supplies that are transported through international supply chains.

According to Precedence Research, the global healthcare third-party logistics market size was valued at USD 255.07 billion in 2025 and is projected to grow from USD 274.56 billion in 2026 to approximately USD 522.87 billion by 2035, expanding at a CAGR of 7.44% from 2026 to 2035, driven by the rising demand for efficient, regulatory-compliant, and temperature-controlled logistics solutions for the transportation and distribution of pharmaceuticals, biologics, vaccines, and other medical products.

Expanding Specialized Healthcare Logistics Services

Through the acquisition UPS Healthcare will be able to utilize AHGs vast transportation and distribution network with a healthcare concentration. AHG is well-known for its specialized warehousing temperature-controlled transportation and last-mile delivery services created especially for medical supplies. UPS hopes to increase healthcare supply chains dependability effectiveness and compliance by incorporating these capabilities.

Advanced logistics solutions are becoming more necessary as the market for biologics specialty drugs, and temperature-sensitive treatments expands. With this acquisition UPS will be in a better position to provide safe and legal transportation services to healthcare manufacturers and providers. It is anticipated that the combined network will offer clients improved service quality and more geographic coverage. Furthermore, UPSs cold-chain infrastructure, which is becoming more crucial for the distribution of gene and cell therapies, is strengthened by the acquisition. Healthcare businesses will be able to lower delivery risks and preserve product integrity throughout the supply chain with the aid of the expanded logistics network.

According to Precedence Research, the healthcare third-party logistics market size is expected to witness substantial growth during the forecast period due to rising pharmaceutical production, increasing adoption of cold-chain logistics, and the growing trend of outsourcing supply chain management activities to specialized logistics providers.

Industry Impact and Market Outlook

The purchase demonstrates the growing consolidation taking place in the healthcare logistics sector as businesses look to bolster international distribution networks and increase specialized capabilities. Logistics companies are making significant investments in infrastructure and strategic acquisitions to meet changing industry demands as the demand for biologics advanced therapies and precision medicines keeps growing.

UPS’s acquisition of AHG demonstrates the growing importance of integrated healthcare supply chain solutions and temperature-controlled logistics services. The transaction is expected to enhance competition in the healthcare third-party logistics market while encouraging further investments in healthcare-focused transportation, warehousing, and distribution technologies. Industry experts expect similar acquisitions to continue as logistics providers seek to build comprehensive healthcare ecosystems capable of supporting pharmaceutical innovation. The deal also reinforces the strategic role of third-party logistics providers in ensuring efficient and resilient healthcare supply chains worldwide.